152 related articles for article (PubMed ID: 23999990)
1. The diverse role of miR-31 in regulating cancer associated phenotypes.
Laurila EM; Kallioniemi A
Genes Chromosomes Cancer; 2013 Dec; 52(12):1103-13. PubMed ID: 23999990
[TBL] [Abstract][Full Text] [Related]
2. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
[TBL] [Abstract][Full Text] [Related]
4. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
5. miR-214: a potential biomarker and therapeutic for different cancers.
Sharma T; Hamilton R; Mandal CC
Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues.
Zhang QH; Sun HM; Zheng RZ; Li YC; Zhang Q; Cheng P; Tang ZH; Huang F
Gene; 2013 Sep; 527(1):26-32. PubMed ID: 23791657
[TBL] [Abstract][Full Text] [Related]
8. miR-21 as a key regulator of oncogenic processes.
Selcuklu SD; Donoghue MT; Spillane C
Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
10. Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation.
Iizuka D; Imaoka T; Nishimura M; Kawai H; Suzuki F; Shimada Y
Radiat Res; 2013 Feb; 179(2):151-9. PubMed ID: 23273170
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
13. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
[TBL] [Abstract][Full Text] [Related]
16. Roles of microRNAs in cancers and development.
Takasaki S
Methods Mol Biol; 2015; 1218():375-413. PubMed ID: 25319665
[TBL] [Abstract][Full Text] [Related]
17. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
18. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Tong AW; Nemunaitis J
Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
20. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
Laurila EM; Sandström S; Rantanen LM; Autio R; Kallioniemi A
Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
